155 related articles for article (PubMed ID: 2000048)
1. Omeprazole and acid peptic disease.
Piper DW; Yeomans ND; Shearman DJ
Med J Aust; 1991 Mar; 154(6):374-5. PubMed ID: 2000048
[No Abstract] [Full Text] [Related]
2. Omeprazole.
Walan A
Baillieres Clin Gastroenterol; 1988 Jul; 2(3):629-40. PubMed ID: 3048454
[No Abstract] [Full Text] [Related]
3. [Therapeutic achlorhydria: for which diseases, when and for how long?].
Koop H; Arnold R
Dtsch Med Wochenschr; 1988 Mar; 113(13):516-8. PubMed ID: 2894969
[No Abstract] [Full Text] [Related]
4. Criteria for use of omeprazole in adult inpatients and outpatients.
Lajoie C
Clin Pharm; 1992 Feb; 11(2):177-9. PubMed ID: 1551300
[No Abstract] [Full Text] [Related]
5. [Omeprazole. Its pharmacology and therapeutic efficacy].
Protzer U; Holtermüller KH
Dtsch Med Wochenschr; 1993 Feb; 118(7):230-9. PubMed ID: 8440164
[No Abstract] [Full Text] [Related]
6. [Anti-H2 and omeprazole in brief therapy of peptic ulcer].
Piai G; Sabbatini F; Mazzacca G
Ann Ital Chir; 1990; 61(1):11-4. PubMed ID: 1978622
[No Abstract] [Full Text] [Related]
7. [Lansoprazole--profile of a new proton pump inhibitor].
Seifert E
Leber Magen Darm; 1994 Mar; 24(2):66-8, 71. PubMed ID: 8196467
[TBL] [Abstract][Full Text] [Related]
8. Clinical perspectives of drugs inhibiting acid secretion--H+K+-ATPase inhibitors.
Walan A
Scand J Gastroenterol Suppl; 1986; 125():50-4. PubMed ID: 3029857
[TBL] [Abstract][Full Text] [Related]
9. Omeprazole: implications for therapy of peptic ulcer and reflux oesophagitis.
Bium AL
Digestion; 1989; 44 Suppl 1():87-91. PubMed ID: 2691314
[TBL] [Abstract][Full Text] [Related]
10. Omeprazole: a comprehensive review.
Massoomi F; Savage J; Destache CJ
Pharmacotherapy; 1993; 13(1):46-59. PubMed ID: 8437967
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility and safety of omeprazole.
Walan A
Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():107-11. PubMed ID: 2657279
[TBL] [Abstract][Full Text] [Related]
12. Omeprazole in the treatment of Zollinger-Ellison syndrome and histamine H2-antagonist refractory ulcers.
Meijer JL; Jansen JB; Lamers CB
Digestion; 1989; 44 Suppl 1():31-9. PubMed ID: 2575060
[TBL] [Abstract][Full Text] [Related]
13. [Strong inhibition of gastric acid secretion: when is it justifiable?].
Dobrilla G; Amplaz S; Benvenuti S; Bertozzo A
G Clin Med; 1990; 71(8-9):521-6. PubMed ID: 1980653
[No Abstract] [Full Text] [Related]
14. H+/K+-adenosine triphosphatase inhibitors. A new approach to the treatment of acid-peptic diseases.
Lamers CB
Digestion; 1989; 44 Suppl 1():92-5. PubMed ID: 2691316
[TBL] [Abstract][Full Text] [Related]
15. The clinical utility and safety of omeprazole.
Walan A
Scand J Gastroenterol Suppl; 1989; 166():140-4; discussion 145. PubMed ID: 2574908
[TBL] [Abstract][Full Text] [Related]
16. Omeprazole.
Maton PN
N Engl J Med; 1991 Apr; 324(14):965-75. PubMed ID: 2002819
[No Abstract] [Full Text] [Related]
17. [Omeprazole. A new substance for inhibiting acid production].
Uhl D
Med Monatsschr Pharm; 1990 Feb; 13(2):34-7. PubMed ID: 2179691
[No Abstract] [Full Text] [Related]
18. [The present state of knowledge on the treatment of peptic diseases with cimetidine].
Romankiewicz JA; Reidenberg MM
Internist (Berl); 1981 Dec; 22(12):762-6. PubMed ID: 6797984
[No Abstract] [Full Text] [Related]
19. [Indications and use of omeprazole in esophago-gastro-duodenal diseases].
Martín de Argila C; Boixeda de Miquel D; Moreira Vicente V; García Plaza A
Rev Clin Esp; 1999 Nov; 199(11):729-39. PubMed ID: 10638238
[No Abstract] [Full Text] [Related]
20. Is there a need for strong gastric acid inhibition in clinical practice?
Lamers CB
Digestion; 1989; 44 Suppl 1():4-8. PubMed ID: 2691309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]